Back

No Feature content logo

Optimizing Site Selection for Phase III Oncology Clinical Trial

Posted by Jennie

41 days ago

Discover how a pharmaceutical company leveraged advanced analytics to streamline site selection for a Phase III oncology trial, ensuring efficient patient recruitment and high-quality data collection. Learn how integrating patient demographics, investigator profiles, and social determinants of health can enhance trial outcomes and accelerate drug development.

Get Your Copy
Please fill out the required information.

First Name is required.
Last Name is required.
Business Email is required.
Job Title is required.
Company Name is required.